Drugmaker Indivior is to divest its interest in the Sai Bo Song opioid addiction tablet in China in a deal worth up to 122.5 million US dollars (£93.6 million). Drugmaker Indivior is to divest its interest in the Sai Bo Song opioid addiction tablet in China in a deal worth up to 122.5 million US dollars (£93.6 million). Indivior will offload its rights to Zhejiang Pukang Biotechnology as it looks to focus on its core Sublocade and Perseris products. Indivior may receive an additional 105 million US dollars based on technical assistance provided to Zhejiang Pukang and hitting sales targets during a ten-year period. Indivior had been granted a temporary restraining order by the US District Court for the District of New Jersey against Alvogen on January 24.

Source: Irish Independent February 04, 2019 08:48 UTC